SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘8-K’ for 1/14/20

On:  Tuesday, 1/14/20, at 8:02am ET   ·   For:  1/14/20   ·   Accession #:  1157523-20-66   ·   File #:  1-35547

Previous ‘8-K’:  ‘8-K’ on 12/20/19 for 12/18/19   ·   Next:  ‘8-K’ on 1/28/20 for 1/27/20   ·   Latest:  ‘8-K’ on / for 4/25/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/14/20  Allscripts Healthcare Soluti… Inc 8-K:2,7,9   1/14/20   12:3.1M                                   Business Wire/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Allscripts Healthcare Solutions, Inc. 8-K           HTML     28K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     17K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     42K 
12: R1          Document and Entity Information                     HTML     49K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- a52158287_htm                       XML     15K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.LAB  XBRL Labels -- mdrx-20200114_lab                     XML     66K 
 6: EX-101.PRE  XBRL Presentations -- mdrx-20200114_pre              XML     47K 
 4: EX-101.SCH  XBRL Schema -- mdrx-20200114                         XSD     15K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    21K 
 8: ZIP         XBRL Zipped Folder -- 0001157523-20-000066-xbrl      Zip     23K

‘8-K’   —   Allscripts Healthcare Solutions, Inc. 8-K

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX: 
 i false i 000112480400011248042020-01-142020-01-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________________

FORM  i 8-K
________________________
 
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):  i January 14, 2020

________________________

 
 i ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)

________________________


 i Delaware
 
 i 001-35547
 
 i 36-4392754
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

 
 i 222 Merchandise Mart Plaza,  i Suite 2024,  i Chicago,  i Illinois  i 60654
(Address of Principal Executive Offices) (Zip Code)
 
Registrant’s Telephone Number, Including Area Code: ( i 312)  i 506-1200
 
 
 
(Former Name or Former Address, if Changed Since Last Report)
 
________________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicated by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
Trading Symbol
Name of Each Exchange on which Registered
 i Common Stock, par value $0.01 per share
 i MDRX
 i The Nasdaq Stock Market LLC
(Nasdaq Global Select Market)

Item 2.02.  Results of Operations and Financial Condition.
 
On January 14, 2020, Allscripts Healthcare Solutions, Inc. (“Allscripts”) issued a press release regarding Allscripts’ preliminary financial results for the fourth quarter ended December 31, 2019. A copy of the press release is attached hereto as Exhibit 99.1.
 
The information furnished pursuant to this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
 
Item 7.01.  Regulation FD Disclosure
 
On January 15, 2020, Allscripts will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California. A copy of the Company’s presentation is furnished as Exhibit 99.2. The Company intends to use this presentation at other investor conferences.
 
The information furnished pursuant to this Item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
Item 9.01.  Financial Statements and Exhibits.
 
 
(d)  Exhibits.
 
 The following exhibits are furnished herewith:
 
Exhibit No.
  
Description
99.1
  
Press release issued by Allscripts Healthcare Solutions, Inc. on January 14, 2020
     
99.2
  
Copy of Allscripts Healthcare Solutions, Inc. presentation slides

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
Date:  January 14, 2020 
 
 
By: 
 
 
Chief Financial Officer
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
1/15/20
Filed on / For Period end:1/14/20
12/31/1910-K
 List all Filings 
↑Top
Filing Submission 0001157523-20-000066   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 26, 1:03:16.2pm ET